| pubmed-article:15183955 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15183955 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:15183955 | lifeskim:mentions | umls-concept:C0031001 | lld:lifeskim |
| pubmed-article:15183955 | lifeskim:mentions | umls-concept:C0334267 | lld:lifeskim |
| pubmed-article:15183955 | lifeskim:mentions | umls-concept:C0729865 | lld:lifeskim |
| pubmed-article:15183955 | lifeskim:mentions | umls-concept:C0023983 | lld:lifeskim |
| pubmed-article:15183955 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:15183955 | pubmed:dateCreated | 2004-6-8 | lld:pubmed |
| pubmed-article:15183955 | pubmed:abstractText | To report our experience with bacille Calmette-Guérin (BCG) perfusion therapy for transitional cell carcinoma in situ of the upper urinary tract. BCG perfusion therapy is widely used to treat transitional cell carcinoma in situ of the upper urinary tract. However, it has not yet been established as a standard treatment. | lld:pubmed |
| pubmed-article:15183955 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15183955 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15183955 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15183955 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15183955 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15183955 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:15183955 | pubmed:issn | 1527-9995 | lld:pubmed |
| pubmed-article:15183955 | pubmed:author | pubmed-author:HayashiMikioM | lld:pubmed |
| pubmed-article:15183955 | pubmed:author | pubmed-author:EguchiJiroJ | lld:pubmed |
| pubmed-article:15183955 | pubmed:author | pubmed-author:NomataKoichir... | lld:pubmed |
| pubmed-article:15183955 | pubmed:author | pubmed-author:NoguchiMitsur... | lld:pubmed |
| pubmed-article:15183955 | pubmed:author | pubmed-author:YamashitaShuj... | lld:pubmed |
| pubmed-article:15183955 | pubmed:author | pubmed-author:HayashidaYasu... | lld:pubmed |
| pubmed-article:15183955 | pubmed:author | pubmed-author:KogaSigehikoS | lld:pubmed |
| pubmed-article:15183955 | pubmed:author | pubmed-author:KanatakeHiros... | lld:pubmed |
| pubmed-article:15183955 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:15183955 | pubmed:volume | 63 | lld:pubmed |
| pubmed-article:15183955 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15183955 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15183955 | pubmed:pagination | 1084-8 | lld:pubmed |
| pubmed-article:15183955 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15183955 | pubmed:meshHeading | pubmed-meshheading:15183955... | lld:pubmed |
| pubmed-article:15183955 | pubmed:meshHeading | pubmed-meshheading:15183955... | lld:pubmed |
| pubmed-article:15183955 | pubmed:meshHeading | pubmed-meshheading:15183955... | lld:pubmed |
| pubmed-article:15183955 | pubmed:meshHeading | pubmed-meshheading:15183955... | lld:pubmed |
| pubmed-article:15183955 | pubmed:meshHeading | pubmed-meshheading:15183955... | lld:pubmed |
| pubmed-article:15183955 | pubmed:meshHeading | pubmed-meshheading:15183955... | lld:pubmed |
| pubmed-article:15183955 | pubmed:meshHeading | pubmed-meshheading:15183955... | lld:pubmed |
| pubmed-article:15183955 | pubmed:meshHeading | pubmed-meshheading:15183955... | lld:pubmed |
| pubmed-article:15183955 | pubmed:meshHeading | pubmed-meshheading:15183955... | lld:pubmed |
| pubmed-article:15183955 | pubmed:meshHeading | pubmed-meshheading:15183955... | lld:pubmed |
| pubmed-article:15183955 | pubmed:meshHeading | pubmed-meshheading:15183955... | lld:pubmed |
| pubmed-article:15183955 | pubmed:meshHeading | pubmed-meshheading:15183955... | lld:pubmed |
| pubmed-article:15183955 | pubmed:meshHeading | pubmed-meshheading:15183955... | lld:pubmed |
| pubmed-article:15183955 | pubmed:meshHeading | pubmed-meshheading:15183955... | lld:pubmed |
| pubmed-article:15183955 | pubmed:meshHeading | pubmed-meshheading:15183955... | lld:pubmed |
| pubmed-article:15183955 | pubmed:meshHeading | pubmed-meshheading:15183955... | lld:pubmed |
| pubmed-article:15183955 | pubmed:meshHeading | pubmed-meshheading:15183955... | lld:pubmed |
| pubmed-article:15183955 | pubmed:meshHeading | pubmed-meshheading:15183955... | lld:pubmed |
| pubmed-article:15183955 | pubmed:meshHeading | pubmed-meshheading:15183955... | lld:pubmed |
| pubmed-article:15183955 | pubmed:meshHeading | pubmed-meshheading:15183955... | lld:pubmed |
| pubmed-article:15183955 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15183955 | pubmed:articleTitle | Long-term effects of bacille Calmette-Guérin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract. | lld:pubmed |
| pubmed-article:15183955 | pubmed:affiliation | Department of Urology, Nagasaki University School of Medicine, Nagasaki, Japan. | lld:pubmed |
| pubmed-article:15183955 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15183955 | pubmed:publicationType | Clinical Trial | lld:pubmed |
